Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.

Stegmann KA, Björkström NK, Veber H, Ciesek S, Riese P, Wiegand J, Hadem J, Suneetha PV, Jaroszewicz J, Wang C, Schlaphoff V, Fytili P, Cornberg M, Manns MP, Geffers R, Pietschmann T, Guzmán CA, Ljunggren HG, Wedemeyer H.

Gastroenterology. 2010 May;138(5):1885-97. doi: 10.1053/j.gastro.2010.01.051. Epub 2010 Feb 2.

PMID:
20334827
2.

Stable cytotoxic T cell escape mutation in hepatitis C virus is linked to maintenance of viral fitness.

Uebelhoer L, Han JH, Callendret B, Mateu G, Shoukry NH, Hanson HL, Rice CM, Walker CM, Grakoui A.

PLoS Pathog. 2008 Sep 5;4(9):e1000143. doi: 10.1371/journal.ppat.1000143.

3.

Hepatitis C virus infection induces apoptosis through a Bax-triggered, mitochondrion-mediated, caspase 3-dependent pathway.

Deng L, Adachi T, Kitayama K, Bungyoku Y, Kitazawa S, Ishido S, Shoji I, Hotta H.

J Virol. 2008 Nov;82(21):10375-85. doi: 10.1128/JVI.00395-08. Epub 2008 Sep 3.

4.

Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation.

Kato T, Choi Y, Elmowalid G, Sapp RK, Barth H, Furusaka A, Mishiro S, Wakita T, Krawczynski K, Liang TJ.

Hepatology. 2008 Sep;48(3):732-40. doi: 10.1002/hep.22422.

5.

Modulation of natural killer cells by human cytomegalovirus.

Wilkinson GW, Tomasec P, Stanton RJ, Armstrong M, Prod'homme V, Aicheler R, McSharry BP, Rickards CR, Cochrane D, Llewellyn-Lacey S, Wang EC, Griffin CA, Davison AJ.

J Clin Virol. 2008 Mar;41(3):206-12. Review.

6.

Hepatitis C virus infection and apoptosis.

Fischer R, Baumert T, Blum HE.

World J Gastroenterol. 2007 Sep 28;13(36):4865-72. Review.

7.

The SH3 binding motif of HCV [corrected] NS5A protein interacts with Bin1 and is important for apoptosis and infectivity.

Nanda SK, Herion D, Liang TJ.

Gastroenterology. 2006 Mar;130(3):794-809. Erratum in: Gastroenterology. 2006 Aug;131(2):687.

PMID:
16530520
8.

Hepatitis C -- identifying patients with progressive liver injury.

Feld JJ, Liang TJ.

Hepatology. 2006 Feb;43(2 Suppl 1):S194-206. Review.

PMID:
16447261
9.

Relation between viral fitness and immune escape within the hepatitis C virus protease.

Söderholm J, Ahlén G, Kaul A, Frelin L, Alheim M, Barnfield C, Liljeström P, Weiland O, Milich DR, Bartenschlager R, Sällberg M.

Gut. 2006 Feb;55(2):266-74. Epub 2005 Aug 16.

10.

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.

Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, Habermann A, Kräusslich HG, Mizokami M, Bartenschlager R, Liang TJ.

Nat Med. 2005 Jul;11(7):791-6. Epub 2005 Jun 12. Erratum in: Nat Med. 2005 Aug;11(8):905.

11.

Apoptosis: a mechanism of acute and chronic liver injury.

Guicciardi ME, Gores GJ.

Gut. 2005 Jul;54(7):1024-33. Review. No abstract available.

12.

Complete replication of hepatitis C virus in cell culture.

Lindenbach BD, Evans MJ, Syder AJ, Wölk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM.

Science. 2005 Jul 22;309(5734):623-6. Epub 2005 Jun 9.

13.

Robust hepatitis C virus infection in vitro.

Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV.

Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9294-9. Epub 2005 Jun 6.

14.

Near completely humanized liver in mice shows human-type metabolic responses to drugs.

Tateno C, Yoshizane Y, Saito N, Kataoka M, Utoh R, Yamasaki C, Tachibana A, Soeno Y, Asahina K, Hino H, Asahara T, Yokoi T, Furukawa T, Yoshizato K.

Am J Pathol. 2004 Sep;165(3):901-12.

15.

Viral mimicry of cytokines, chemokines and their receptors.

Alcami A.

Nat Rev Immunol. 2003 Jan;3(1):36-50. Review.

PMID:
12511874
16.

Role for heat shock proteins in the immune response to measles virus infection.

Oglesbee MJ, Pratt M, Carsillo T.

Viral Immunol. 2002;15(3):399-416. Review.

PMID:
12479391
17.

Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease.

Thimme R, Bukh J, Spangenberg HC, Wieland S, Pemberton J, Steiger C, Govindarajan S, Purcell RH, Chisari FV.

Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15661-8. Epub 2002 Nov 19.

18.

Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees.

Bukh J, Pietschmann T, Lohmann V, Krieger N, Faulk K, Engle RE, Govindarajan S, Shapiro M, St Claire M, Bartenschlager R.

Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14416-21. Epub 2002 Oct 21.

19.

A battle for survival: immune control and immune evasion in murine gamma-herpesvirus-68 infection.

Stevenson PG, Boname JM, de Lima B, Efstathiou S.

Microbes Infect. 2002 Sep;4(11):1177-82. Review.

PMID:
12361918
20.

Determinants of viral clearance and persistence during acute hepatitis C virus infection.

Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV.

J Exp Med. 2001 Nov 19;194(10):1395-406.

Supplemental Content

Support Center